Second Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 20-23 April 2010.
Thursday 22nd April 2010 (afternoon)
Click here to view the full Conference Programme for this afternoon.
BHIVA / BASHH Lunchtime Workshop 4: Difficult pharmacology case presentations
Cirrhosis: a revealer of truths?
Dr Vanessa Apea, Barts and The London NHS Trust
Raltegravir: a niche in late pregnancy
Dr Melanie Rosenvinge, St George's Hospital, London
Tale of the unexpected?
Dr Ben Stone, Royal Hallamshire Hospital, Sheffield
BHIVA / BASHH Lunchtime Workshop 5 - Transitional care of adolescents with STIs and HIV
Transitional care for HIV and STIs 1
Dr Karen Rogstad, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Perinatally Acquired HIV
Caroline Foster, Imperial College London
Key issues in a transitional care service
Dr Katia Prime, St George's Hospital, London
Transitional care for HIV and STIs 4
Dr Karen Rogstad, Royal Hallamshire Hospital, Sheffield
BHIVA / BASHH Lunchtime Workshop 6
Skills: Setting up a newfill clinic
Ms Sharron Brown, Chelsea and Westminster Hospital, London
Dr Gillian Dean, Royal Sussex County Hospital, Brighton
Oral Research Presentations Session 4: Complications of HIV or treatment
O25: Downregulation of genes controlling fatty acid metabolism and anaerobic respiration in subcutaneous adipose tissue after 18–24 months’ antiviral treatment with efavirenz-containing regimens
Dr Sat Das, University of Warwick
O26: Baseline renal function is an independent predictor of death and progression to severe chronic kidney disease
Dr Lisa Hamzah, King's College Hospital, London
O27: The value of urine protein/creatinine (uPCR) and albumin/creatinine ratios (uACR) in assessing renal disease in HIV infection
Dr Amanda Samarawickrama, Brighton and Sussex University Hospitals NHS Trust
O28: Epidemiology and outcomes of hepatitis delta infection in a large, ethnically diverse UK HIV cohort
Dr Tanya Welz, King’s College Hospital, London
O29: High rates of asymptomatic neurocognitive impairment are observed in perinatally HIV-infected adolescents
Mr Yaso Paramesparan, Imperial College London
O30: Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case–control study
Dr Collins Iwuji, Brighton and Sussex University Hospitals NHS Trust
O31: A study to assess the impact of the D:A:D study on clinical practice
Dr Leann Johnson, North Manchester General Hospital
O32: Can KSHV viral load be used to differentiate multicentric Castleman’s disease from Kaposi’s sarcoma?
Dr Ruth Fish, Mortimer Market Centre, London
O33: Non-germinal centre subtype of AIDS-related diffuse large B-cell lymphomas associated with improved survival
Prof Mark Bower, Chelsea and Westminster Hospital, London
Oral Research Presentations Session 5: New technologies, interventions and treatments
O34: Are self-taken vaginal swabs an effective way of finding gonorrhoea? A comparison of the detection of Neisseria gonorrhoea by Gen-Probe Aptima Combo 2 AC2 assay performed on self-taken vulvo-vaginal swabs (VVSs) versus culture performed on clinician-taken urethral and endocervical swabs
Dr Catherine Stewart, Leeds Teaching Hospitals Trust
O35: Comparison of culture and Gen-Probe Aptima Combo 2® assay for the detection of Neisseria gonorrhoeae from throat and rectal specimens in MSM
Dr Charlotte Fite, Assistance Publique des Hôpitaux de Paris
O36: Risk factors for acquisition of lymphogranuloma venereum: results of a multi-centre case–control study in the UK
Prof Helen Ward, Imperial College London
O37: Clinical presentation of Lymphogranuloma venereum in a multi-centre case–control study in the UK: LGV-net
Dr Sanjeeva Pallawela, Chelsea and Westminster NHS Foundation Trust, London
O38: What is the best specimen site for detecting Chlamydia trachomatis in women with and without symptoms?
Dr Sarah Schoeman, Leeds Teaching Hospitals Trust
O39: A pilot comparative study of the Chlamydia trachomatis Pgp3 antibody ELISA and two C. trachomatis-specific MOMP peptide assays on sera from young people in the community
Dr Gillian Wills, Imperial College London
O40: One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection
Dr Ali Elgalib, Guy's & St Thomas' NHS Foundation Trust, London
O41: Antimicrobial Resistance in Chlamydia trachomatis, is it a reality?
Dr Sarah Alexander, Health Protection Agency, London
O42 Contamination of chlamydia and gonorrhoea samples in the clinic
Miss Gail Dube, Whittall Street Clinic, Birmingham
BHIVA Audit Session
Hepatitis B and C in HIV-co-infected patients
Dr Lucy Garvey, St Mary’s Hospital, London
BHIVA / BASHH Plenary Session 3
HPV vaccination: strategies and outcomes
Professor Margaret Stanley, University of Cambridge
Changing UK practice: influence from resource-poor settings, including new infant feeding guidance
Dr Gareth Tudor-Williams, Imperial College London